Acute myeloid leukemia (AML) is a heterogeneous disease, and survival signatures are urgently needed to better monitor treatment. MiRNAs displayed vital regulatory roles on target genes, which was nec
Additional file 1: Supplementary Figure 1. [S1] Voronoi diagram of the superpathway and its children, yellow indicates matched entities and gradient represents p-value for [A] GSE5550, [B] Combined da
